{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:47:58Z","timestamp":1792036078461,"version":"4.4.0"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017649","name":"Government of the Hong Kong Special Administrative Region of the People","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017649","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.addr.2025.115646","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T12:53:47Z","timestamp":1751633627000},"page":"115646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"special_numbering":"C","title":["From cell-SELEX to tissue-SELEX for targeted drug delivery and aptamer nanomedicine"],"prefix":"10.1016","volume":"224","author":[{"given":"Ka-Ying","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Sau","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Heon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5918-9336","authenticated-orcid":false,"given":"Juewen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2025.115646_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17488","article-title":"Advances in drug delivery systems, challenges and future directions","volume":"9","author":"Ezike","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.addr.2025.115646_b0010","unstructured":"J. Kim, O. De Jesus, Medication Routes of Administration, in: StatPearls, StatPearls Publishing, Treasure Island (FL), 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK568677\/ (accessed March 20, 2025)."},{"key":"10.1016\/j.addr.2025.115646_b0015","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1021\/acs.molpharmaceut.6b00445","article-title":"Prolonged ocular retention of mucoadhesive nanoparticle eye drop formulation enables treatment of eye diseases using significantly reduced dosage","volume":"13","author":"Liu","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2025.115646_b0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1208\/s12249-023-02516-9","article-title":"Ocular drug delivery: a comprehensive review","volume":"24","author":"Ahmed","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2025.115646_b0025","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/pharmaceutics16020248","article-title":"Different targeting ligands-mediated drug delivery systems for tumor therapy","volume":"16","author":"Yan","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2025.115646_b0030","doi-asserted-by":"crossref","first-page":"12133","DOI":"10.1021\/acs.chemrev.7b00013","article-title":"Ligand-targeted drug delivery","volume":"117","author":"Srinivasarao","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.addr.2025.115646_b0035","doi-asserted-by":"crossref","first-page":"52553","DOI":"10.18632\/oncotarget.9651","article-title":"Targeting folate receptor alpha for cancer treatment","volume":"7","author":"Cheung","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.addr.2025.115646_b0040","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1039\/C7SC04004K","article-title":"Advances in targeting the folate receptor in the treatment\/imaging of cancers","volume":"9","author":"Fern\u00e1ndez","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.addr.2025.115646_b0045","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.addr.2004.01.009","article-title":"Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential","volume":"56","author":"Lu","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2025.115646_b0050","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jconrel.2021.12.013","article-title":"Benefits and challenges of antibody drug conjugates as novel form of chemotherapy","volume":"341","author":"Fatima","year":"2022","journal-title":"J. Control. Release off. J. Control. Release Soc."},{"key":"10.1016\/j.addr.2025.115646_b0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev-med-050311-201823","article-title":"Antibody-drug conjugates in cancer therapy","volume":"64","author":"Sievers","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.addr.2025.115646_b0060","unstructured":"FDA Approved Antibody-Drug Conjugates (ADCs) By 2025 | Biopharma PEG, (n.d.). https:\/\/www.biochempeg.com\/article\/74.html (accessed March 20, 2025)."},{"key":"10.1016\/j.addr.2025.115646_b0065","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3390\/molecules29051124","article-title":"Aptamer technologies in neuroscience, neuro-diagnostics and neuro-medicine development","volume":"29","author":"Wang","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.addr.2025.115646_b0070","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1039\/D4TB02180K","article-title":"The application of aptamers in the repair of bone, nerve, and vascular tissues","volume":"13","author":"Hsu","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.addr.2025.115646_b0075","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.3390\/ijms25136833","article-title":"New insights into aptamers: an alternative to antibodies in the detection of molecular biomarkers","volume":"25","author":"Domsicova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2025.115646_b0080","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2025.115646_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2025.118349","article-title":"Aptamer-based biosensors: from SELEX to biomedical diagnostics","volume":"191","author":"Stangherlin","year":"2025","journal-title":"TrAC, Trends Anal. Chem."},{"key":"10.1016\/j.addr.2025.115646_b0090","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/anie.201006630","article-title":"Nucleic acid and peptide aptamers: fundamentals and bioanalytical aspects","volume":"51","author":"Mascini","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2025.115646_b0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","article-title":"Aptamers as targeted therapeutics: current potential and challenges","volume":"16","author":"Zhou","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2025.115646_b0100","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1021\/acsami.0c05750","article-title":"Recent progress in aptamer discoveries and modifications for therapeutic applications","volume":"13","author":"Ni","year":"2021","journal-title":"ACS Appl. Mater. Interf."},{"key":"10.1016\/j.addr.2025.115646_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068810","article-title":"Potential capacity of aptamers to trigger immune activation in human blood","volume":"8","author":"Avci-Adali","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.addr.2025.115646_b0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/nat.2015.0575","article-title":"2\u2032fluoro modification differentially modulates the ability of RNAs to activate pattern recognition receptors","volume":"26","author":"Lee","year":"2016","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.addr.2025.115646_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.968862","article-title":"The role of microenvironment in stem cell-based regeneration of intervertebral disc","volume":"10","author":"Chu","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.addr.2025.115646_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2025.101350","article-title":"The recent blooming of therapeutic aptamers","volume":"102","author":"Cesarini","year":"2025","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.addr.2025.115646_b0125","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/nprot.2010.66","article-title":"Development of DNA aptamers using Cell-SELEX","volume":"5","author":"Sefah","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.addr.2025.115646_b0130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.omtn.2020.05.025","article-title":"Aptamers against live targets: is in vivo SELEX finally coming to the edge?","volume":"21","author":"Sola","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.addr.2025.115646_b0135","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.addr.2025.115646_b0140","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0022-2836(91)90509-5","article-title":"Selexion: systematic evolution of ligands by exponential enrichment with integrated optimization by non-linear analysis","volume":"222","author":"Irvine","year":"1991","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.addr.2025.115646_b0145","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202318665","article-title":"Development of better aptamers: structured library approaches, selection methods, and chemical modifications","volume":"63","author":"Brown","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2025.115646_b0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fchem.2016.00014","article-title":"Small-molecule binding aptamers: selection strategies, characterization, and applications","volume":"4","author":"Ruscito","year":"2016","journal-title":"Front. Chem."},{"key":"10.1016\/j.addr.2025.115646_b0155","doi-asserted-by":"crossref","first-page":"11838","DOI":"10.1073\/pnas.0602615103","article-title":"Aptamers evolved from live cells as effective molecular probes for cancer study","volume":"103","author":"Shangguan","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2025.115646_b0160","article-title":"An overview of Sgc8 aptamer as a potential theranostic agent for cancer with PTK7 oncogenic target","volume":"108","author":"Wang","year":"2025","journal-title":"Sci. Prog."},{"key":"10.1016\/j.addr.2025.115646_b0165","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1021\/acs.analchem.1c01445","article-title":"Identification of a New DNA Aptamer by Tissue-SELEX for Cancer Recognition and Imaging","volume":"93","author":"Li","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.addr.2025.115646_b0170","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1038\/mtna.2012.59","article-title":"In vivo SELEX for Identification of Brain-penetrating Aptamers","volume":"2","author":"Cheng","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.addr.2025.115646_b0175","doi-asserted-by":"crossref","first-page":"15416","DOI":"10.1073\/pnas.2136683100","article-title":"A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment","volume":"100","author":"Daniels","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2025.115646_b0180","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.3390\/ijms17122079","article-title":"Development of cell-SELEX technology and its application in cancer diagnosis and therapy","volume":"17","author":"Chen","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2025.115646_b0185","first-page":"1","article-title":"Nucleic acid aptamer application in diagnosis and therapy of colorectal cancer based on cell-SELEX technology","volume":"1","author":"Chen","year":"2017","journal-title":"Npj Precis. Oncol."},{"key":"10.1016\/j.addr.2025.115646_b0190","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.yexcr.2016.01.015","article-title":"3D Cell-SELEX: development of RNA aptamers as molecular probes for PC-3 tumor cell line","volume":"341","author":"Souza","year":"2016","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.addr.2025.115646_b0195","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.omtn.2023.03.015","article-title":"Development of DNA aptamers for visualization of glial brain tumors and detection of circulating tumor cells","volume":"32","author":"Kichkailo","year":"2023","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.addr.2025.115646_b0200","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1021\/acsnano.2c11675","article-title":"Aptamer nanoconstructs crossing human blood\u2013brain barrier discovered via microphysiological system-based SELEX Technology","volume":"17","author":"Choi","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2025.115646_b0205","doi-asserted-by":"crossref","first-page":"34","DOI":"10.32607\/20758251-2013-5-4-34-43","article-title":"Aptamers: problems, solutions and prospects","volume":"5","author":"Lakhin","year":"2013","journal-title":"Acta Nat."},{"key":"10.1016\/j.addr.2025.115646_b0210","doi-asserted-by":"crossref","first-page":"24329","DOI":"10.1021\/acsnano.3c10238","article-title":"Investigation of the relationship between aptamers\u2019 targeting functions and human plasma proteins","volume":"17","author":"Liu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2025.115646_b0215","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1021\/acssensors.9b00342","article-title":"A nucleus-targeting DNA aptamer for dead cell indication","volume":"4","author":"Shen","year":"2019","journal-title":"ACS Sens."},{"key":"10.1016\/j.addr.2025.115646_b0220","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/nprot.2010.163","article-title":"Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures","volume":"5","author":"Mayer","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.addr.2025.115646_b0225","doi-asserted-by":"crossref","first-page":"26667","DOI":"10.1021\/jacs.4c03129","article-title":"Efficient strategy to discover DNA aptamers against low abundance cell surface proteins in scarce samples","volume":"146","author":"Wu","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2025.115646_b0230","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/path.2543","article-title":"Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX","volume":"218","author":"Li","year":"2009","journal-title":"J. Pathol."},{"key":"10.1016\/j.addr.2025.115646_b0235","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1021\/acs.analchem.9b01000","article-title":"Identification and application of an aptamer targeting papillary thyroid carcinoma using tissue-SELEX","volume":"91","author":"Zhong","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.addr.2025.115646_b0240","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1021\/acs.analchem.9b00609","article-title":"Identification of vigilin as a potential ischemia biomarker by brain slice-based systematic evolution of ligands by exponential enrichment","volume":"91","author":"Liu","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.addr.2025.115646_b0245","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2144\/000114473","article-title":"Morph-X-Select: morphology-based tissue aptamer selection for ovarian cancer biomarker discovery","volume":"61","author":"Wang","year":"2016","journal-title":"BioTechniques"},{"key":"10.1016\/j.addr.2025.115646_b0250","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41467-018-03631-z","article-title":"Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes","volume":"9","author":"Domenyuk","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2025.115646_b0255","article-title":"Cornea\u2010SELEX for aptamers targeting the surface of eyes and liposomal drug delivery","volume":"4","author":"Wong","year":"2024","journal-title":"Exploration"},{"key":"10.1016\/j.addr.2025.115646_b0260","article-title":"Identification of in Vivo internalizing cardiac-specific RNA aptamers","author":"Narayan","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.addr.2025.115646_b0265","doi-asserted-by":"crossref","DOI":"10.1063\/1.5050451","article-title":"Microfluidic platforms for rapid screening of cancer affinity reagents by using tissue samples","volume":"12","author":"Hung","year":"2018","journal-title":"Biomicrofluidics"},{"key":"10.1016\/j.addr.2025.115646_b0270","series-title":"IEEE 33rd Int Conf. Micro Electro Mech. Syst. MEMS","first-page":"1083","article-title":"An automated microfluidic system for optimization of aptamer selection by using cancer tissue samples","author":"Lin","year":"2020"},{"key":"10.1016\/j.addr.2025.115646_b0275","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1039\/D0LC01333A","article-title":"Optimization of aptamer selection on an automated microfluidic system with cancer tissues","volume":"21","author":"Lin","year":"2021","journal-title":"Lab. Chip"},{"key":"10.1016\/j.addr.2025.115646_b0280","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1039\/C8BM00787J","article-title":"Differentiating breast cancer molecular subtypes using a DNA aptamer selected against MCF-7 cells","volume":"6","author":"Liu","year":"2018","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.addr.2025.115646_b0285","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/ijms25020840","article-title":"Aptamer-based recognition of breast tumor cells: a new era for breast cancer diagnosis","volume":"25","author":"de Ara\u00fajo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2025.115646_b0290","doi-asserted-by":"crossref","first-page":"8614","DOI":"10.1038\/s41598-021-87998-y","article-title":"Selection of aptamers against triple negative breast cancer cells using high throughput sequencing","volume":"11","author":"Ferreira","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2025.115646_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126450","article-title":"A truncated DNA aptamer with high selectivity for estrogen receptor-positive breast cancer cells","volume":"252","author":"Cong","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.addr.2025.115646_b0300","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1039\/D1AN00182E","article-title":"PD-L1 aptamer isolation via Modular-SELEX and its applications in cancer cell detection and tumor tissue section imaging","volume":"146","author":"Li","year":"2021","journal-title":"Analyst"},{"key":"10.1016\/j.addr.2025.115646_b0305","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1002\/anie.201916039","article-title":"Homogeneous, low-volume, efficient, and sensitive quantitation of circulating exosomal PD-L1 for cancer diagnosis and immunotherapy response prediction","volume":"59","author":"Huang","year":"2020","journal-title":"Angew. Chem. Int. Ed Engl."},{"key":"10.1016\/j.addr.2025.115646_b0310","first-page":"e925583-1","article-title":"A PD-L1 aptamer selected by loss-gain cell-SELEX conjugated with paclitaxel for treating triple-negative breast cancer","volume":"26","author":"Wu","year":"2020","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.addr.2025.115646_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.339066","article-title":"A highly specific aptamer probe targeting PD-L1 in tumor tissue sections: mutation favours specificity","volume":"1185","author":"Ren","year":"2021","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.addr.2025.115646_b0320","doi-asserted-by":"crossref","DOI":"10.1021\/acsbiomaterials.4c02053","article-title":"Aptamer-Assisted DNA SELEX: dual-site targeting of a single protein","author":"Silwal","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.addr.2025.115646_b0325","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1126\/science.aan4183","article-title":"Defective cholesterol clearance limits remyelination in the aged central nervous system","volume":"359","author":"Cantuti-Castelvetri","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.addr.2025.115646_b0330","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/bio.2012.0031","article-title":"Stabilization of tissue specimens for pathological examination and biomedical research","volume":"10","author":"Unhale","year":"2012","journal-title":"Biopreservation Biobanking"},{"key":"10.1016\/j.addr.2025.115646_b0335","doi-asserted-by":"crossref","first-page":"16489","DOI":"10.1021\/bi981780f","article-title":"Novel combinatorial selection of phosphorothioate oligonucleotide aptamers","volume":"37","author":"King","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2025.115646_b0340","doi-asserted-by":"crossref","unstructured":"L. Neves Rebello Alves, D. Dummer Meira, L. Poppe Merigueti, M. Correia Casotti, D. do Prado Ventorim, J. Ferreira Figueiredo Almeida, V. Pereira de Sousa, M. Cindra Sant\u2019Ana, R. Gon\u00e7alves Coutinho da Cruz, L. Santos Louro, G. Mendon\u00e7a Santana, T. Erik Santos Louro, R. Evangelista Salazar, D. Ribeiro Campos da Silva, A. Stefani Siqueira Zetum, R. Silva dos Reis Trabach, F. Imbroisi Valle Errera, F. de Paula, E. de Vargas Wolfgramm dos Santos, E. Fagundes de Carvalho, I. Drumond Louro, Biomarkers in Breast Cancer: An Old Story with a New End, Genes 14 (2023) 1364. https:\/\/doi.org\/10.3390\/genes14071364.","DOI":"10.3390\/genes14071364"},{"key":"10.1016\/j.addr.2025.115646_b0345","first-page":"1","article-title":"Beyond laser microdissection technology: follow the yellow brick road for cancer research","volume":"4","author":"Legres","year":"2014","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.addr.2025.115646_b0350","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1021\/acs.bioconjchem.3c00205","article-title":"Ongoing clinical trials of nonviral siRNA therapeutics","volume":"34","author":"Narasipura","year":"2023","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2025.115646_b0355","article-title":"The application of microfluidic technologies in aptamer selection","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.addr.2025.115646_b0360","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/2211068216659255","article-title":"An integrated microfluidic SELEX approach using combined electrokinetic and hydrodynamic manipulation","volume":"22","author":"Olsen","year":"2017","journal-title":"SLAS Technol."},{"key":"10.1016\/j.addr.2025.115646_b0365","doi-asserted-by":"crossref","first-page":"10326","DOI":"10.1038\/srep10326","article-title":"Screening of aptamers specific to colorectal cancer cells and stem cells by utilizing On-chip Cell-SELEX","volume":"5","author":"Hung","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2025.115646_b0370","doi-asserted-by":"crossref","DOI":"10.1063\/1.5085133","article-title":"An automated microfluidic system for selection of aptamer probes against ovarian cancer tissues","volume":"13","author":"Liu","year":"2019","journal-title":"Biomicrofluidics"},{"key":"10.1016\/j.addr.2025.115646_b0375","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nchembio.277","article-title":"In vivo selection of tumor-targeting RNA motifs","volume":"6","author":"Mi","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.addr.2025.115646_b0380","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1039\/C7AN01046J","article-title":"Microfluidic methods for aptamer selection and characterization","volume":"143","author":"Dembowski","year":"2017","journal-title":"The Analyst"},{"key":"10.1016\/j.addr.2025.115646_b0385","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cbpa.2008.06.028","article-title":"SELEX with modified nucleotides","volume":"12","author":"Keefe","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.addr.2025.115646_b0390","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1007\/s11095-004-7676-4","article-title":"Pharmacokinetics and biodistribution of novel aptamer compositions","volume":"21","author":"Healy","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2025.115646_b0395","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2147\/IJN.S188003","article-title":"In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis model","volume":"14","author":"Chen","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2025.115646_b0400","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.omtn.2017.12.003","article-title":"In Vivo SELEX of an Inhibitory NSCLC-Specific RNA Aptamer from PEGylated RNA Library","volume":"10","author":"Wang","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.addr.2025.115646_b0405","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1038\/s41598-019-41460-2","article-title":"Targeting hormone refractory prostate cancer by in vivo selected DNA libraries in an orthotopic xenograft mouse model","volume":"9","author":"Civit","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2025.115646_b0410","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1078-0432.CCR-22-1585","article-title":"Leptomeningeal metastasis from non\u2013small cell lung cancer and current landscape of treatments","volume":"29","author":"Ozcan","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2025.115646_b0415","doi-asserted-by":"crossref","first-page":"27905","DOI":"10.1021\/acsnano.4c04680","article-title":"AptBCis1 an aptamer\u2013cisplatin conjugate, is effective in lung cancer leptomeningeal carcinomatosis","volume":"18","author":"Huang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2025.115646_b0420","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.drudis.2019.02.001","article-title":"Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties","volume":"24","author":"Subrizi","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2025.115646_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102352","article-title":"Targeting ocular tissues with intravenously administered aptamers selected by in vivo SELEX","volume":"35","author":"Korhonen","year":"2024","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.addr.2025.115646_b0430","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fgene.2012.00234","article-title":"Current progress of RNA aptamer-based therapeutics","volume":"3","author":"Zhou","year":"2012","journal-title":"Front. Genet."},{"key":"10.1016\/j.addr.2025.115646_b0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033583510000181","article-title":"Nucleases: diversity of Structure, Function and Mechanism","volume":"44","author":"Yang","year":"2011","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.addr.2025.115646_b0440","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1048148","article-title":"Strategies for developing long-lasting therapeutic nucleic acid aptamer targeting circulating protein:the present and the future","volume":"10","author":"Zhang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.addr.2025.115646_b0445","article-title":"Recent advances in aptamer discovery, modification and improving performance","volume":"40","author":"Fallah","year":"2024","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.addr.2025.115646_b0450","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fchem.2016.00018","article-title":"Modified nucleoside triphosphates for in-vitro selection techniques","volume":"4","author":"Dellafiore","year":"2016","journal-title":"Front. Chem."},{"key":"10.1016\/j.addr.2025.115646_b0455","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.chembiol.2004.10.017","article-title":"Direct In Vitro selection of a 2\u2032-O-Methyl Aptamer to VEGF","volume":"12","author":"Burmeister","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.addr.2025.115646_b0460","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/biomedicines9040433","article-title":"The challenges and strategies of antisense oligonucleotide drug delivery","volume":"9","author":"Gagliardi","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.addr.2025.115646_b0465","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/nat.2017.0680","article-title":"Effect of chemical modifications on aptamer stability in serum","volume":"27","author":"Kratschmer","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.addr.2025.115646_b0470","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1038\/s41598-019-42523-0","article-title":"Systematic evaluation of 2\u2032-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro","volume":"9","author":"Chen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2025.115646_b0475","doi-asserted-by":"crossref","first-page":"20556","DOI":"10.1074\/jbc.273.32.20556","article-title":"2\u2019-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain","volume":"273","author":"Ruckman","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2025.115646_b0480","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2025.115646_b0485","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/asia.200900421","article-title":"Engineering dendritic aptamer assemblies as superior inhibitors of protein function","volume":"5","author":"Kim","year":"2010","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.addr.2025.115646_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.bj.2023.100685","article-title":"Aptamer-functionalized liposomes for drug delivery","volume":"47","author":"Wong","year":"2024","journal-title":"Biomed. J."},{"key":"10.1016\/j.addr.2025.115646_b0495","article-title":"Chemically modified aptamers for improving binding affinity to the target proteins via enhanced non-covalent bonding","volume":"11","author":"Chen","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.addr.2025.115646_b0500","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1007\/s11426-015-5367-0","article-title":"Adipo8, a high-affinity DNA aptamer, can differentiate among adipocytes and inhibit intracellular lipid accumulation in vitro","volume":"58","author":"Chen","year":"2015","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.addr.2025.115646_b0505","doi-asserted-by":"crossref","first-page":"8321","DOI":"10.1021\/bi300471d","article-title":"X-Aptamers: a bead-based selection method for random incorporation of druglike moieties onto next-generation aptamers for enhanced binding","volume":"51","author":"He","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2025.115646_b0510","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.gendis.2022.07.002","article-title":"Identification of new aptamer BC-3 targeting RPS7 from rapid screening for bladder carcinoma","volume":"10","author":"Liu","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.addr.2025.115646_b0515","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1128\/JVI.76.13.6689-6700.2002","article-title":"Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway","volume":"76","author":"Liu","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2025.115646_b0520","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1006\/mthe.2001.0495","article-title":"Generation of species cross-reactive aptamers using \u201ctoggle\u201d SELEX","volume":"4","author":"White","year":"2001","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.addr.2025.115646_b0525","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/nat.2017.0711","article-title":"Cell-SELEX-based identification of a human and mouse cross-reactive endothelial cell-internalizing aptamer","volume":"28","author":"Dua","year":"2018","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.addr.2025.115646_b0530","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12935-024-03295-4","article-title":"Aptamers as an approach to targeted cancer therapy","volume":"24","author":"Mahmoudian","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.addr.2025.115646_b0535","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.addr.2018.08.005","article-title":"Aptamer-based targeted therapy","volume":"134","author":"Zhu","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2025.115646_b0540","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1039\/D3TB00598D","article-title":"Mucin-targeting-aptamer functionalized liposomes for delivery of cyclosporin a for dry eye diseases","volume":"11","author":"Wong","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.addr.2025.115646_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102299","article-title":"Topical DNA aptamer therapeutics for the skin","volume":"35","author":"Shiu","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.addr.2025.115646_b0550","first-page":"457","article-title":"Size matters: gold nanoparticles in targeted cancer drug delivery","volume":"3","author":"Dreaden","year":"2012","journal-title":"Taylor Francis"},{"key":"10.1016\/j.addr.2025.115646_b0555","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0009-2797(03)00061-9","article-title":"New findings in the study on the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA","volume":"145","author":"Haj","year":"2003","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.addr.2025.115646_b0560","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14309\/crj.2015.63","article-title":"Polyethylene glycol (PEG)-induced anaphylactic reaction during bowel preparation","volume":"2","author":"Gachoka","year":"2015","journal-title":"ACG Case Rep. J."},{"key":"10.1016\/j.addr.2025.115646_b0565","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1157\/13120396","article-title":"Immediate allergic reactions by polyethylene glycol 4000: two cases","volume":"36","author":"Ant\u00f3n Giron\u00e9s","year":"2008","journal-title":"Allergol. Immunopathol. (Madr.)"},{"key":"10.1016\/j.addr.2025.115646_b0570","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1021\/acs.biomac.6b00238","article-title":"Site-specific albumination as an alternative to PEGylation for the enhanced serum half-life in Vivo","volume":"17","author":"Yang","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2025.115646_b0575","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cbpa.2015.08.009","article-title":"Protein-polymer conjugation-moving beyond PEGylation","volume":"28","author":"Qi","year":"2015","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.addr.2025.115646_b0580","doi-asserted-by":"crossref","first-page":"8313","DOI":"10.1021\/ac0613582","article-title":"Maximizing DNA loading on a range of gold nanoparticle sizes","volume":"78","author":"Hurst","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.addr.2025.115646_b0585","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41571-023-00850-2","article-title":"Exploring the next generation of antibody\u2013drug conjugates","volume":"21","author":"Tsuchikama","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.addr.2025.115646_b0590","first-page":"1","article-title":"Antibody drug conjugate: the \u201cbiological missile\u201d for targeted cancer therapy","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.addr.2025.115646_b0595","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/mt.2016.182","article-title":"The mucus barrier to inhaled gene therapy","volume":"24","author":"Duncan","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2025.115646_b0600","article-title":"Monolithic DNApatite: an elastic apatite with sub\u2010nanometer scale organo\u2013inorganic structures","volume":"35","author":"Lee","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2025.115646_b0605","doi-asserted-by":"crossref","first-page":"14975","DOI":"10.1021\/acs.langmuir.7b03204","article-title":"Interfacing DNA oligonucleotides with calcium phosphate and other metal phosphates","volume":"34","author":"Wang","year":"2018","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2025.115646_b0610","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jconrel.2018.01.002","article-title":"Gold nanoparticle should understand protein corona for being a clinical nanomaterial","volume":"272","author":"Charbgoo","year":"2018","journal-title":"J. Control. Release off. J. Control. Release Soc."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X25001310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X25001310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:40:55Z","timestamp":1778946055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X25001310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":122,"alternative-id":["S0169409X25001310"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2025.115646","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From cell-SELEX to tissue-SELEX for targeted drug delivery and aptamer nanomedicine","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2025.115646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115646"}}